3,4-cyclic phosphate sodium narcistatin

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 石蒜科生物碱
• 英文名称: 3,4-cyclic phosphate sodium narcistatin
• 英文别名: sodium nacistatin；sodium;(13R,14S,18R,19S)-16,19-dihydroxy-11,16-dioxo-5,7,15,17-tetraoxa-12-aza-16lambda5-phosphapentacyclo[11.7.0.02,10.04,8.014,18]icosa-1(20),2,4(8),9-tetraen-9-olate；sodium;(13R,14S,18R,19S)-16,19-dihydroxy-11,16-dioxo-5,7,15,17-tetraoxa-12-aza-16λ5-phosphapentacyclo[11.7.0.02,10.04,8.014,18]icosa-1(20),2,4(8),9-tetraen-9-olate
• 化学式: C₁₄H₁₁NO₉P*Na
• 分子量: 391.206
• InChiKey: PDHVRYDRIJXVHV-WAJBGZTRSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -3.75
• 重原子数：
  26
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  147
• 氢给体数：
  3
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  (3aS,3bR,12S,12aR)-2,6,12-Trihydroxy-2-oxo-3b,4,12,12a-tetrahydro-3aH-1,3,7,9-tetraoxa-4-aza-2λ⁵-phospha-dicyclopenta[a,h]phenanthren-5-one; compound with pyridine 在 Dowex 50W-X₂ (Na(+) form) 作用下， 以 水 为溶剂， 以87%的产率得到3,4-cyclic phosphate sodium narcistatin
  参考文献：
  名称：

  Antineoplastic Agents 500. Narcistatin^,1

  摘要：

  An efficient procedure was found for synthetic conversion of the sparingly soluble anticancer isocarbostyril narciclasine (1), a component of various Narcissus species, to a cyclic phosphate designated narcistatin (3b). The reaction between narciclasine, tetrabutylammonium. dihydrogen phosphate, and p-toluenesulfonic acid in pyridine afforded pyridinium narcistatin (3a) in reasonable yields. Transformation of narcistatin (3a) to, for example, the water-soluble prodrug sodium narcistatin (3d) was easily achieved by cation exchange chromatography. Narcistatin (3b) and 15 salt derivatives were evaluated against a panel of human cancer cell lines, and the range (0.1-0.01) of GI(50) values in mug/mL was found to parallel that shown by the parent narciclasine.

  DOI：

  10.1021/np020225i

文献信息

• [EN] SYNTHESIS OF SODIUM NARCISTATIN AND RELATED COMPOUNDS<br/>[FR] SYNTHESE DE NARCISTATINE DE SODIUM ET COMPOSES ASSOCIES
  申请人：STATE OF ARIZONA ACTING FOR AN

  公开号：WO2006076726A1

  公开（公告）日：2006-07-20

  (EN) The present invention involves use of the compounds narciclasine (2a) and 7-deoxy-narciclasine (2c), which are obtained via isolation from the medicinal plant species Narcissus (Amaryllidaceae), as precursors in a novel synthesis method in which each of these compounds are selectively hydrogenated to produce trans-dihydronarciclasine (1a) and 7-deoxy-trans-dihydronarciclasine (1c). Also described herein is a novel synthesis method for producing sodium narcistatin (11) from narciclasine (2a). Further described herein are certain novel 3,4-cyclic phosphate prodrugs, including sodium-7-deoxynarcistatin (8), sodium-7-deoxy-transdihydronarcistatin (9), and sodium transdihydronarcistatin (10).(FR) L'invention concerne l'utilisation de composés narciclasine (2a) et 7-déoxy-narciclasine (2c), obtenus par isolation à partir de l'espèce végétale médicinale Narcissus (Amaryllidaceae), en tant que précurseurs dans un nouveau procédé de synthèse dans lequel chacun de ces composés est sélectivement hydrogéné afin que soient produites de la trans-dihydronarciclasine (1a) et de la 7-déoxy-trans-dihydronarciclasine (1c). L'invention concerne également un nouveau procédé de synthèse pour la production de narcistatine de sodium (11) à partir de narciclasine (2a). L'invention concerne en outre certains nouveaux promédicaments de phosphate 3,4 cyclique, à savoir : sodium-7-déoxynarcistatine (8), sodium-7-déoxy-transdihydronarcistatine (9), et sodium transdihydronarcistatine (10).

  本发明涉及使用从医用植物品种水仙属（石蒜科）中分离得到的化合物narciclasine（2a）和7-去氧-narciclasine（2c）作为前体，进行新型合成方法，其中每个化合物都被选择性氢化以产生trans-dihydronarciclasine（1a）和7-去氧-trans-dihydronarciclasine（1c）。本文还描述了一种从narciclasine（2a）制备钠narcistatin（11）的新型合成方法。此外，本文还描述了某些新型3,4-环磷酸酯前药，包括：sodium-7-deoxynarcistatin（8）、sodium-7-deoxy-transdihydronarcistatin（9）和sodium transdihydronarcistatin（10）。